about
Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.Spinal cord involvement in pediatric systemic lupus erythematosus: case report and literature review.The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.Cogan's syndrome in childhood.Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry.Consequences of disease-causing mutations on lubricin protein synthesis, secretion, and post-translational processing.Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaborationA retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic.Phenotypic characteristics and outcome of juvenile dermatomyositis in Arab children.Juvenile idiopathic arthritis in multiplex families: longitudinal follow-up.Development of the autoinflammatory disease damage index (ADDI).Familial aggregation of Crohn's disease and necrotizing sarcoid-like granulomatous disease.Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children.Periodic fever, rash and arthropathy in a child.Hemophagocytosis complicating Kawasaki disease.Evaluation of parental knowledge of Pediatric Rheumatic Diseases.Marked variability in clinical presentation and outcome of patients with C1q immunodeficiency.Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.Hypergammaglobulinaemic purpura associated with IgG subclass imbalance and recurrent infection.Juvenile dermatomyositis: clinical profile and disease course in 25 patients.Chronic recurrent multifocal osteomyelitis: a first report from Saudi Arabia.The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome.Cyclic intravenous pamidronate treatment in children with nodulosis, arthropathy and osteolysis syndrome.The Arabic version of childhood health assessment questionnaire modified for Arabic children.Interstitial pneumonitis and air leakage in juvenile dermatomyositis.Granulomatous disease in a child treated with etanercept.Infections associated with juvenile systemic lupus erythematosus.Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.Ocular manifestations of systemic lupus erythematosus in children.The use of corticosteroid therapy in refractory Kawasaki patients.Systemic lupus erythematosus in Arab children. Differences and similarities with different ethnicities.Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.Dissecting the heterogeneity of macrophage activation syndrome.Systemic lupus erythematosus in Saudi children: long-term outcomes.PW02-037 - The Eurofever cohort of 136 patients with CAPS.Extensive ulcerations due to pyoderma gangrenosum in a child with juvenile systemic lupus erythematosus and C1q deficiency.Infantile systemic hyalinosis: a fatal disorder commonly diagnosed among Arabs.
P50
Q33411406-CA9A817F-5E48-4635-99FE-0C8397DD6780Q33721214-DF084308-7AC3-4A3A-AB6E-E1F6782E57D5Q33885438-2764BC4C-2C9B-4131-B25C-DD23206D3AB9Q34063502-47C9E38C-80AD-4E1A-8378-EE7550558C42Q34111632-30197784-A957-4AD3-8158-C152AE845DAEQ34285481-038E6E49-B20D-45F7-969C-ACA201F11CD3Q34373857-BE1AC68A-3546-4A7C-8BC3-7877193B82A8Q34429717-266923C9-E121-4D18-99BD-2925B25FA6A8Q34431660-2064A450-874C-4101-98FE-D502A8AD91A6Q35102471-3C9D21B2-012C-4656-A8CE-671D96438EE2Q37966720-9ECBE377-47C8-4186-8B9E-962361FAED14Q38690044-FCD78D12-A8B4-47AC-918D-087F666C135CQ38781266-F949E125-F7CC-4E00-81B6-56610F4A1935Q38997969-CC94EFB3-C652-40E6-82A3-3CB9BBF86518Q40086222-AA3F9A94-05B0-4AB1-8A63-74DAD310B99EQ40255424-7C167984-A457-46EF-A94B-83E159864B74Q40494682-BC5B9CED-4972-43AA-A011-222425C32BEBQ40620425-2EF6CB69-3C77-4658-95AF-67BAB4D01F8CQ40700276-65E55566-F91F-40B1-89AE-D3D2F8773446Q40788987-E251BE52-D8C3-4054-9820-C9E64438658AQ41068374-71C90D2D-EA21-41DF-A56D-AA67F267AEF1Q41920552-5C127D56-9F9F-4B55-B35D-49B8820C75F7Q41924481-11F1CC19-8888-47E5-A708-65F8A7ED1F4EQ42275665-389E4FCC-5926-4AD3-913D-490930044E4CQ42316448-FE1ACCA2-B1FA-4797-BF7F-219598E09AC9Q42955130-615D77D3-1D94-46E1-837F-2B93F8BF64E4Q43307887-3FC5ACCD-0B92-4FA3-A260-9AD49D7F1849Q43616488-A1FB8048-28F0-4625-97A1-8782B6B29735Q44026066-C86A4B3E-CB08-4C56-8107-93239E41DADEQ44197892-535006DA-2AE0-4FA8-8A06-2F8FF2A289D9Q44213785-690F8528-56FE-48C6-9D18-E9D2F906DBEFQ44584504-B3008AEB-14DB-4C18-A39A-224A2E622131Q44746938-20F5C70E-8678-49CB-8B4B-A1895E3693D0Q44986097-CB290FE2-1AFF-4E3C-B263-7864B28ED3E1Q44996535-2FB2BA48-4A58-485C-91DC-106D3E9BA32BQ45779353-4B513910-F107-4144-A344-18DAF471720FQ45942560-44066822-8F56-4C3F-A5EC-FF5A3A9D3780Q46052716-689144E8-8F44-46A6-B63C-1565AC9A3C9FQ46244916-C58D719F-25C0-4DDA-8507-7C86470A61DCQ46712254-648F52F3-47CD-4DCE-BD65-FFB3687220D0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sulaiman M Al-Mayouf
@ast
Sulaiman M Al-Mayouf
@en
Sulaiman M Al-Mayouf
@es
Sulaiman M Al-Mayouf
@sl
type
label
Sulaiman M Al-Mayouf
@ast
Sulaiman M Al-Mayouf
@en
Sulaiman M Al-Mayouf
@es
Sulaiman M Al-Mayouf
@sl
altLabel
almayouf s
@en
prefLabel
Sulaiman M Al-Mayouf
@ast
Sulaiman M Al-Mayouf
@en
Sulaiman M Al-Mayouf
@es
Sulaiman M Al-Mayouf
@sl
P106
P21
P31
P496
0000-0003-0142-6698